Molecular structure of CAY10449
CAY10449
See product citations (1)
Application:
CAY10449 is antagonizes the carbaprostacyclin-induced activation of human neuroblastoma adenylate cyclase, blocking cyclic AMP accumulation in a dose-dependent manner. Likewise, it inhibits the binding of tritiated iloprost to rodent neuroblastoma cells with a Ki of about 3 nM.
Molecular Weight:
323.39
Molecular Formula:
C19H21N3O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Potent compounds with high-affinity ligands and functional antagonists for the human IP (prostacyclin) receptor.1 Antagonizes the carbaprostacyclin-induced activation of human neuroblastoma adenylate cyclase, blocking cyclic AMP accumulation in a dose-dependent manner. Likewise, it inhibits the binding of tritiated iloprost to rodent neuroblastoma cells with a Ki of about 3 nM.1
CAY10449 References
1 Clark, R.D., Jahangir, A., Severance, D., et al. Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists. Bioorg Medicinal Chem Letters 14 1053-1056 (2004).Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CAY10449, 1 mg | sc-223863 | 1 mg | $92.00 | |||
CAY10449, 5 mg | sc-223863A | 5 mg | $311.00 |